Hépato-Gastro & Oncologie Digestive
MENUThe bright future of hepatology! Second part Volume 24, issue 9, Novembre 2017
33604 Pessac, France
service d’hépatologie, Bâtiment Jacques Caroli - 8e étage, 184, rue du Faubourg Saint Antoine 75571 Paris Cedex 12, France
- Key words: cirrhosis, hepatocellular carcinoma, liver transplantation, research
- DOI : 10.1684/hpg.2017.1526
- Page(s) : 929-40
- Published in: 2017
This second part of the “bright future of hepatology” is devoted to the successes and challenges at the interface between public health, preventive medicine, translational research and international health policy. Indeed, cirrhosis is a disease which prevalence is increasing in France and beyond our borders. Huge challenges remain in the future in terms of prevention which includes alcohol and metabolic syndrome management, screening and early diagnosis. Primary tumors of the liver will always be in the years a public health problem because very related in France to alcohol and the metabolic syndrome. They will represent a significant part of the activity of hepatologists who play and will play a major role in the screening and organization of care. The emergence of new therapeutic tools (targeted therapies, immunotherapy) will transform the treatment of HCC and justify the acquisition of oncology skills by hepatologists who will increase accurate management of both liver and tumor disease that we cannot dissociate. Access to screening and treatment in countries of the South stay problematic and deserve our attention in a globalized world.